ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Biosimilar Drug Updates Reported from EULAR

Michele B. Kaufman, PharmD, BCGP  |  July 8, 2015

At the 2015 meeting of the European League Against Rheumatism in June, multiple studies were presented comparing the use of different biosimilar and biologic drugs in treating rheumatoid arthritis…

Filed under:Biologics/DMARDsDrug UpdatesEULAR/OtherMeeting Reports Tagged with:adalimumabBiologics & BiosimilarsetanerceptEULARRheumatiod arthritis

Many Healthcare Providers Come to Work Sick

Kathryn Doyle  |  July 7, 2015

(Reuters Health)—Many doctors, nurses, midwives and physician assistants come to work sick even though they know it puts patients at risk, a new survey hints. Many said they don’t call in sick because they don’t want to let colleagues or patients down by taking a sick day, and they were concerned about finding staff to…

Filed under:Practice SupportWorkforce Tagged with:immunocompromisedphysician practicesPractice Managementrheumatologists

E-Learning in Physiotherapy

Arthritis Care & Research  |  July 7, 2015

A physiotherapy-specific, Web-based e-learning platform, “RAP-el,” was studied to determine its effectiveness in assisting physiotherapists with the best-practice management of rheumatoid arthritis (RA). It was shown to improve self-reported confidence, likely practice behaviors and satisfaction in physiotherapists’ ability to manage people with RA, and improve their clinical knowledge in several areas…

Filed under:ConditionsResearch RheumRheumatoid ArthritisTechnology Tagged with:Arthritis Care & Researchlearning toolsPhysical TherapyRheumatiod arthritis

After Default, Fight Breaks Out Over Greek Medicine Supplies

Ben Hirschler  |  July 6, 2015

LONDON (Reuters)—Wholesalers trading medicines across European borders have criticized a suggestion by manufacturers that Greek exports should be restricted to prevent shortages of life-saving drugs in the country. Such trade, which allows traders to buy products in low-cost markets and sell them where prices are higher, is allowed under EU free trade rules. But drugmakers…

Filed under:Drug Updates

Guselkumab Studied to Treat RA & Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2015

In a Phase 2 study, researchers evaluated the effectiveness of guselkumab to alleviate symptoms in patients with active RA suffering from tender and swollen joints.

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:EULARguselkumabMethotrexateplaque psoriasisRheumatoid arthritisustekinumab

Greece’s Medicine Supply May Be in Jeopardy

Ben Hirschler  |  June 29, 2015

BASEL, Switzerland (Reuters)—Drugmakers said on Monday they would continue to ship medicines to Greece in coming weeks, despite mounting unpaid bills, but warned supplies could be in jeopardy if Europe did not take emergency action. “In the worst-case scenario of ‘Grexit’, we believe the integrity of the medicines supply chain may be in jeopardy, which…

Filed under:Drug Updates Tagged with:Drug shortageEuropean UnionGreece

Lungs Are Particularly Vulnerable in Patients with Systemic Rheumatic Disease

Lara C. Pullen, PhD  |  June 29, 2015

In an observational study, physicians found that systemic rheumatic disease exacerbation and treatment-related infections were often related to the lungs…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:critical care managementInfectionlungrheumatologySystemic Rheumatic Diseases

U.S. Supreme Court Upholds Obamacare Insurance Subsidies

Lawrence Hurley  |  June 25, 2015

WASHINGTON (Reuters)—The U.S. Supreme Court preserved President Barack Obama’s signature healthcare law on Thursday, upholding crucial tax subsidies while turning aside a conservative legal challenge that could have doomed the law. “After more than 50 votes in Congress to repeal or weaken this law, after a presidential election based in part on preserving or repealing…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Health InsuranceLegislationObamacareSupreme Court

Antirheumatic Drugs May Be Linked to Pulmonary Toxicity & More

Michele B. Kaufman, PharmD, BCGP  |  June 24, 2015

At a recent symposium, Kristin Highland, MD, reported on the use of antirheumatic treatments, specifically methotrexate, and their connections with pulmonary toxicity in patients.

Filed under:Drug Updates Tagged with:ACR 2015 State-of-the-Art Clinical SymposiumDisease-modifying antirheumatic drugs (DMARDs)Methotrexatepulmonary toxicity

Many Psoriasis Patients Have Undiagnosed Arthritis

Kathryn Doyle  |  June 23, 2015

(Reuters Health)—Up to 15% of people with psoriasis have undiagnosed arthritis that’s related to the skin condition, according to a new review. “The important takeaway,” said Dr. Abby Van Voorhees, director of the Psoriasis and Phototherapy Treatment Center at the Hospital of the University of Pennsylvania in Philadelphia, “would be that further education is needed…

Filed under:ConditionsPsoriatic Arthritis Tagged with:DermatologyPsoriasispsoriatic arthritis

  • « Previous Page
  • 1
  • …
  • 246
  • 247
  • 248
  • 249
  • 250
  • …
  • 330
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences